A different point mutation in c-KIT (N822K T > A) constitutively activates this receptor, making AML cells highly sensitive to sunitinib (a tyrosine kinase inhibitor), resulting in AML cell death through the activation of both apoptosis and autophagy processes [145]. This evidence concerns the gene KIT and acute myeloid leukemia.